LivaNova PLC (NASDAQ: LIVN) on Monday, plunged -4.15% from the previous trading day, before settling in for the closing price of $51.13. Within the past 52 weeks, LIVN’s price has moved between $42.75 and $64.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.30%. The company achieved an average annual earnings per share of 19.52%. With a float of $54.10 million, this company’s outstanding shares have now reached $54.30 million.
Let’s determine the extent of company efficiency that accounts for 2900 employees. In terms of profitability, gross margin is 67.79%, operating margin of 0.32%, and the pretax margin is -5.03%.
LivaNova PLC (LIVN) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of LivaNova PLC is 0.37%, while institutional ownership is 103.60%. The most recent insider transaction that took place on Sep 11 ’24, was worth 69,870. In this transaction Director of this company sold 1,500 shares at a rate of $46.58, taking the stock ownership to the 8,772 shares. Before that another transaction happened on Sep 11 ’24, when Company’s Director proposed sale 1,500 for $46.58, making the entire transaction worth $69,870.
LivaNova PLC (LIVN) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.87 earnings per share (EPS) for the period topping the consensus outlook (set at 0.77) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.8 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.52% per share during the next fiscal year.
LivaNova PLC (NASDAQ: LIVN) Trading Performance Indicators
LivaNova PLC (LIVN) is currently performing well based on its current performance indicators. A quick ratio of 2.87 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.13. Likewise, its price to free cash flow for the trailing twelve months is 24.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.43, a number that is poised to hit 0.80 in the next quarter and is forecasted to reach 3.65 in one year’s time.
Technical Analysis of LivaNova PLC (LIVN)
Looking closely at LivaNova PLC (NASDAQ: LIVN), its last 5-days average volume was 0.84 million, which is a jump from its year-to-date volume of 0.62 million. As of the previous 9 days, the stock’s Stochastic %D was 11.62%. Additionally, its Average True Range was 1.64.
During the past 100 days, LivaNova PLC’s (LIVN) raw stochastic average was set at 41.27%, which indicates a significant increase from 3.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.18% in the past 14 days, which was lower than the 28.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.10, while its 200-day Moving Average is $52.96. However, in the short run, LivaNova PLC’s stock first resistance to watch stands at $50.35. Second resistance stands at $51.70. The third major resistance level sits at $52.51. If the price goes on to break the first support level at $48.19, it is likely to go to the next support level at $47.38. Should the price break the second support level, the third support level stands at $46.03.
LivaNova PLC (NASDAQ: LIVN) Key Stats
Market capitalization of the company is 2.64 billion based on 54,298K outstanding shares. Right now, sales total 1,154 M and income totals 17,550 K. The company made 318,580 K in profit during its latest quarter, and 16,330 K in sales during its previous quarter.
